معرفی
Dr. Musa Marimani is a Lecturer in the Department of Anatomical Pathology at the University of the Witwatersrand Medical School, Johannesburg, South Africa. He holds a PhD from the same institution. His research focuses on epigenetic mechanisms underlying HIV and tuberculosis (TB) co-infection, particularly how viral and bacterial pathogens disrupt host immunity through epigenetic modifications like methylation, phosphorylation, and acetylation. He explores these mechanisms to develop diagnostic biomarkers and novel therapies. His work also addresses antimicrobial resistance, drug delivery systems, and natural product-based therapeutics.
Education:
- BSc (University of the Witwatersrand)
- BSc Honours (University of the Witwatersrand)
- MSc (University of the Witwatersrand)
- PhD (University of the Witwatersrand)
Research Interests: Gene therapy, RNA interference, molecular medicine, and microbiology, with emphasis on HIV-TB co-infection, epigenetic regulation, and antimicrobial resistance. His projects aim to identify therapeutic targets and biomarkers for improved diagnostics and treatment regimens.
Publications: His recent work includes studies on epigenetic regulation in co-infected patients, nanoemulsion drug carriers for multi-drug resistance, and natural products against pathogens like Candida auris and Listeria monocytogenes. A notable focus is on host-pathogen interactions and the development of novel therapies to combat drug-resistant infections.
Grants/Advising: No specific grants or student advising roles are detailed in the provided information.
Labs/Teams: Research conducted within the University of the Witwatersrand’s Medical School, collaborating on interdisciplinary projects in molecular pathology and infectious diseases.
